Titan Spine Appoints Spine Industry Expert Ed Graubart as Vice President of Professional Development

Company notes Graubart to enhance and build Company’s sales training and development infrastructure as demand accelerates for nanoLOCK® surface technology Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced...

New President Named: CIVCO Radiotherapy

CIVCO Radiotherapy, the leading provider of high quality, innovative, patient-centric radiotherapy solutions.

Howard Rosen to its Executive Management Team as VP Marketing and Business Development at Intact Vascular

Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Howard Rosen has joined its executive management team as Vice President of Marketing and Business Development. In this position, Mr....

ReWalk Robotics Names Jodi Gricci Chief Commercial Officer

Jodi Gricci previously served as Vice President, Global Marketing, Training, and Service while ReWalk established each of these functions to support customers.

Heart Test Labs Further Strengthens Board of Directors

The recent additions of Mr. John Q. Adams, Sr. and Mr. John D. Owen to further strengthen its Board of Directors.

New CEO Appointed at Lombard Medical

April 20, 2017 Lombard Medical, Inc. (NASDAQ: EVAR), a developer, manufacturer and marketer of endovascular aortic aneurysm repair products, today announced that Kurt Lemvigh has been appointed as its new Chief Executive Officer, effective immediately. Lombard Medical notes Kurt...

SynteractHCR Adds Another Three Senior Executives To Management Team With Both U.S. and International Clinical Trials Operations Experience

Their newest senior executives include: Heather Davis, executive director of U.S. Project Management; Zia Haque, executive director, Clinical Data Management, and John Whitaker, Ph.D. as executive director, Biostatistics. All will report to Marlo M. Vasquez, vice president, U.S. Operations at SynteractHCR.

ReForm Biologics Appoints John M. Sorvillo, Ph.D., as Chief Executive Officer

April 19, 2017 ReForm Biologics, a pharmaceutical technology company that develops proprietary excipients to improve biologic formulations, announced today that the Company’s Board of Directors has appointed John M. Sorvillo, Ph.D., as Chief Executive Officer. Reform Biologics notes John...